Metabolic lipid muscle disorders

biomarkers and treatment

Corrado Angelini, Elena Pennisi, Sara Missaglia, Daniela Tavian

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Lipid storage myopathies (LSMs) are metabolic disorders of the utilization of fat in muscles due to several different defects. In this review, a molecular update of LSMs is presented and recent attempts of finding treatment options are discussed. The main topics discussed are: primary carnitine deficiency, riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency, neutral lipid storage disorders and carnitine palmitoyl transferase deficiency. The most frequent presentations and genetic abnormalities are summarized. We present their diagnosis utilizing biomedical and morphological biomarkers and possible therapeutic interventions. The treatment of these metabolic disorders is a subject of active translational research but appears, in some cases, still elusive.

Original languageEnglish
JournalTherapeutic Advances in Neurological Disorders
Volume12
DOIs
Publication statusPublished - Apr 1 2019

Fingerprint

Muscular Diseases
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
Biomarkers
Lipids
Translational Medical Research
Riboflavin
Carnitine
Transferases
Fats
Muscles
Myopathy with Abnormal Lipid Metabolism
Therapeutics
Systemic carnitine deficiency

Keywords

  • Carnitine
  • CPTz
  • NLSD
  • Riboflavin
  • β-oxidation

ASJC Scopus subject areas

  • Pharmacology
  • Neurology
  • Clinical Neurology

Cite this

Metabolic lipid muscle disorders : biomarkers and treatment. / Angelini, Corrado; Pennisi, Elena; Missaglia, Sara; Tavian, Daniela.

In: Therapeutic Advances in Neurological Disorders, Vol. 12, 01.04.2019.

Research output: Contribution to journalReview article

Angelini, Corrado ; Pennisi, Elena ; Missaglia, Sara ; Tavian, Daniela. / Metabolic lipid muscle disorders : biomarkers and treatment. In: Therapeutic Advances in Neurological Disorders. 2019 ; Vol. 12.
@article{8f7c7ab3c1904bf9a3baf472605c7462,
title = "Metabolic lipid muscle disorders: biomarkers and treatment",
abstract = "Lipid storage myopathies (LSMs) are metabolic disorders of the utilization of fat in muscles due to several different defects. In this review, a molecular update of LSMs is presented and recent attempts of finding treatment options are discussed. The main topics discussed are: primary carnitine deficiency, riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency, neutral lipid storage disorders and carnitine palmitoyl transferase deficiency. The most frequent presentations and genetic abnormalities are summarized. We present their diagnosis utilizing biomedical and morphological biomarkers and possible therapeutic interventions. The treatment of these metabolic disorders is a subject of active translational research but appears, in some cases, still elusive.",
keywords = "Carnitine, CPTz, NLSD, Riboflavin, β-oxidation",
author = "Corrado Angelini and Elena Pennisi and Sara Missaglia and Daniela Tavian",
year = "2019",
month = "4",
day = "1",
doi = "10.1177/1756286419843359",
language = "English",
volume = "12",
journal = "Therapeutic Advances in Neurological Disorders",
issn = "1756-2856",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Metabolic lipid muscle disorders

T2 - biomarkers and treatment

AU - Angelini, Corrado

AU - Pennisi, Elena

AU - Missaglia, Sara

AU - Tavian, Daniela

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Lipid storage myopathies (LSMs) are metabolic disorders of the utilization of fat in muscles due to several different defects. In this review, a molecular update of LSMs is presented and recent attempts of finding treatment options are discussed. The main topics discussed are: primary carnitine deficiency, riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency, neutral lipid storage disorders and carnitine palmitoyl transferase deficiency. The most frequent presentations and genetic abnormalities are summarized. We present their diagnosis utilizing biomedical and morphological biomarkers and possible therapeutic interventions. The treatment of these metabolic disorders is a subject of active translational research but appears, in some cases, still elusive.

AB - Lipid storage myopathies (LSMs) are metabolic disorders of the utilization of fat in muscles due to several different defects. In this review, a molecular update of LSMs is presented and recent attempts of finding treatment options are discussed. The main topics discussed are: primary carnitine deficiency, riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency, neutral lipid storage disorders and carnitine palmitoyl transferase deficiency. The most frequent presentations and genetic abnormalities are summarized. We present their diagnosis utilizing biomedical and morphological biomarkers and possible therapeutic interventions. The treatment of these metabolic disorders is a subject of active translational research but appears, in some cases, still elusive.

KW - Carnitine

KW - CPTz

KW - NLSD

KW - Riboflavin

KW - β-oxidation

UR - http://www.scopus.com/inward/record.url?scp=85064808118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064808118&partnerID=8YFLogxK

U2 - 10.1177/1756286419843359

DO - 10.1177/1756286419843359

M3 - Review article

VL - 12

JO - Therapeutic Advances in Neurological Disorders

JF - Therapeutic Advances in Neurological Disorders

SN - 1756-2856

ER -